WeilandTJJelinekGAMarckCH, et al. Clinically significant fatigue: Prevalence and associated factors in an international sample of adults with multiple sclerosis recruited via the internet. PLoS ONE2015; 10(2): e0115541.
2.
JanardhanVBakshiR.Quality of life in patients with multiple sclerosis. J Neurol Sci2002; 205: 51–58.
3.
NourbakhshBRevirajanNMorrisB, et al. Safety and efficacy of amantadine, modafinil, and methylphenidate for fatigue in multiple sclerosis: A randomised, placebo-controlled, crossover, double-blind trial. Lancet Neurol2021; 20(1): 38–48.
4.
Moss-MorrisRHarrisonAMSafariR, et al. Which behavioural and exercise interventions targeting fatigue show the most promise in multiple sclerosis? A systematic review with narrative synthesis and meta-analysis. Behav Res Ther2021; 137: 103464.
5.
DalgasUHvidLGKwakkelG, et al. Moving exercise research in multiple sclerosis forward (the MoXFo initiative): Developing consensus statements for research. Mult Scler2020; 26(11): 1303–1308.
6.
Das NairRde GrootVFreemanJ. Beyond current research practice: Methodological considerations in MS rehabilitation research (is designing the perfect rehabilitation trial the Holy Grail or a Gordian knot?). Mult Scler2019; 25(10): 1337–1347.
7.
HarrisonAMSafariRMercerT, et al. Which exercise and behavioural interventions show most promise for treating fatigue in multiple sclerosis? A network meta-analysis. Mult Scler2021; 27(11): 1657–1678.
8.
MillsEJThorlundKIoannidisJPA. Demystifying trial networks and network meta-analysis. BMJ2013; 346: 1–6.
9.
GoveroverYChiaravallotiNDO’BrienAR, et al. Evidenced-based cognitive rehabilitation for persons with multiple sclerosis: An updated review of the literature from 2007 to 2016. Arch Phys Med Rehabil2018; 99(2): 390–407.
10.
CraigPPetticrewM.Developing and evaluating complex interventions: Reflections on the 2008 MRC guidance. Int J Nurs Stud2013; 50(5): 585–587.
